BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1130 related articles for article (PubMed ID: 30299408)

  • 1. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
    Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
    Seeger J; Gonska B; Rottbauer W; Wöhrle J
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
    Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
    Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
    Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications after Transfemoral Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prosthesis: The Importance of Preventative Measures and Contingency Planning.
    Chakravarty T; Jilaihawi H; Doctor N; Fontana G; Forrester JS; Cheng W; Makkar R
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):E29-E42. PubMed ID: 23436313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balloon-expandable transaortic transcatheter aortic valve implantation with or without predilation.
    Bonaros N; Kofler M; Frank D; Cocchieri R; Jagielak D; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Bapat V; Rein KA; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Romano M
    J Thorac Cardiovasc Surg; 2018 Mar; 155(3):915-923. PubMed ID: 29221741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights From the BEAT International Collaborative Registrys.
    Mangieri A; Tchetchè D; Kim WK; Pagnesi M; Sinning JM; Landes U; Kornowski R; De Backer O; Nickenig G; Ielasi A; De Biase C; Søndergaard L; De Marco F; Montorfano M; Chiarito M; Regazzoli D; Stefanini G; Presbitero P; Toggweiler S; Tamburino C; Immè S; Tarantini G; Sievert H; Schäfer U; Kempfert J; Wöehrle J; Gallo F; Laricchia A; Latib A; Giannini F; Colombo A
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e008714. PubMed ID: 32646304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of transfemoral balloon expandable transcatheter aortic valve implantation: Comparison of two subsequent valve generations.
    Schymik G; Wendler O; Hengstenberg C; Ohlmann P; Gilard M; Digne F; Souteyrand G; Letocart V; van Belle E; Bramlage P; Tarantini G;
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):930-939. PubMed ID: 31794159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A feasibility study of transaxillary TAVI with the lotus valve.
    Doshi SN; George S; Kwok CS; Mechery A; Mamas M; Ludman PF; Townend JN; Bhabra M
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):542-549. PubMed ID: 29130619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial.
    Abdel-Wahab M; Landt M; Neumann FJ; Massberg S; Frerker C; Kurz T; Kaur J; Toelg R; Sachse S; Jochheim D; Schäfer U; El-Mawardy M; Robinson DR; Richardt G;
    JACC Cardiovasc Interv; 2020 May; 13(9):1071-1082. PubMed ID: 32305398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of three different new generation transcatheter aortic valve prostheses.
    Costa G; Buccheri S; Barbanti M; Picci A; Todaro D; Di Simone E; La Spina K; D'Arrigo P; Criscione E; Nastasi M; Sgroi C; Tamburino C
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):398-407. PubMed ID: 31609073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioprosthetic Valve Performance After Transcatheter Aortic Valve Replacement With Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli: Insights From the CHOICE Trial and the CHOICE-Extend Registry.
    Abdelghani M; Mankerious N; Allali A; Landt M; Kaur J; Sulimov DS; Merten C; Sachse S; Mehilli J; Neumann FJ; Frerker C; Kurz T; El-Mawardy M; Richardt G; Abdel-Wahab M
    JACC Cardiovasc Interv; 2018 Dec; 11(24):2507-2518. PubMed ID: 30503595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Third-Generation Balloon and Self-Expandable Valves for Aortic Stenosis in Large and Extra-Large Aortic Annuli From the TAVR-LARGE Registry.
    Armijo G; Tang GHL; Kooistra N; Ferreira-Neto AN; Toggweiler S; Amat-Santos IJ; Keller LS; Urena M; Ahmad H; Tafur Soto J; Muñoz-Garcia E; Regueiro A; Leenders GE; Tirado-Conte G; Sengupta A; McInerney A; Couture T; Cuevas Herreros O; Rodriguez-Gabella T; Kini A; Ahmed M; Zaid S; Gonzalo N; Nuñez-Gil IJ; Muñoz-Garcia AJ; Jimenez-Quevedo P; Fernández-Ortiz A; Himbert D; Nietlispach F; Stella P; Dangas GD; Escaned J; Macaya C; Rodés-Cabau J; Nombela-Franco L
    Circ Cardiovasc Interv; 2020 Aug; 13(8):e009047. PubMed ID: 32757657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
    Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repositionable Versus Balloon-Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis.
    Pilgrim T; Stortecky S; Nietlispach F; Heg D; Tueller D; Toggweiler S; Ferrari E; Noble S; Maisano F; Jeger R; Roffi M; Grünenfelder J; Huber C; Wenaweser P; Windecker S
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27856487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The balloon-expandable Edwards Sapien 3 valve is superior to the self-expanding Medtronic CoreValve in patients with severe aortic stenosis undergoing transfemoral aortic valve implantation.
    Gonska B; Seeger J; Baarts J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
    J Cardiol; 2017 Jun; 69(6):877-882. PubMed ID: 27614379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.